DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Loreclezole
Loreclezole
Valerenic Acid Potentiates and Inhibits GABAA Receptors: Molecular Mechanism and Subunit Specificity
GABA Receptors
Anxiety Disorders and GABA Neurotransmission: a Disturbance of Modulation
Molecular Mechanisms of Antiseizure Drug Activity at GABAA Receptors
Characterisation of GABAA Receptors and Cation-Chloride Cotransporters in the Uterus and Their Role in Pre-Term Labour
Ion Channels
Analysis of B-Subunit-Dependent GABA a Receptor Modulation And
The GABAA Receptor Interface: a Novel Target for Subtype Selective Drugs
Loss of the Major GABAA Receptor Subtype in the Brain Is Not Lethal in Mice
Major Differences in Inhibitory Synaptic Transmission Onto Two Neocortical Interneuron Subclasses
GABA Receptors
Methoxy-6-Methylflavone and Kavain at Recombinant GABAA Receptors
GABAA Receptor Pharmacology and Subtype Mrna Expression in Human Neuronal NT2-N Cells
Pediculus Humanus
Submission to the Medicines Classification Committee, Medsafe NZ Chris King – Emeritus University of Auckland
Psychoactive Medications Grouped by Drug Class and Foods Studied Tor Psychoactive Effects
Identifying Drugs That Bind Selectively to Intersubunit General Anesthetic Sites in the Α1β3γ2 GABAAR Transmembrane Domain
Allosteric GABAA Receptor Modulators—A Review on the Most Recent Heterocyclic Chemotypes and † Their Synthetic Accessibility
Top View
Learning Under Stress: Separating the Effects of Allopregnanolone and Fluoxetine in Carassius Auratus
Drug Discrimination: Applications to Drug Abuse Research
REVIEW ARTICLE the GABAA Receptors F
Platform-Dependence of Activity of Positive Allosteric Modulators of Β1- and Β2-Containing GABAA Receptor Subtypes
GABAA Receptor Subtype- and Function-Selective Ligands: Key Issues in Translation to Humans
Allosteric Modulation of GABAA Receptors by Steroids and Related
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
MOL #28597 1 Tonically Active GABAA Receptors in Hippocampal
(12) United States Patent (Io) Patent No.: US 9,526,824 B2 Ferrari Et Al
GABAA Receptor Ligands Often Interact with Binding Sites in the Transmembrane Domain and in the Extracellular Domain—Can the Promiscuity Code Be Cracked?
GABA(A) Receptors As in Vivo Substrate for the Anxiolytic Action of Valerenic Acid, a Major Constituent of Valerian Root Extracts
Wo 2007/044693 A2
Low-Dose Alcohol Actions on 4 3 GABA Receptors Are Reversed by The
Bioactivity of Excoecaria Agallocha
A Thesis Entitled Investigation of Two Interacting Neurosteroid Sites on A
GABA and Sleep
(12) United States Patent (10) Patent No.: US 8,802,596 B2 Rogers Et Al
Synthesis and Biological Evaluation of Pyrroloindolines As Positive Allosteric Modulators of the #1#2#2 GABAA Receptor Annet E.M
Phase 1B Pharmaco-MRS Pilot Study of Clavulanic Acid After Repeated Administration
The Modulatory Action of Loreclezole at the Y-Aminobutyric Acid Type a Receptor Is Determined by a Single Amino Acid in the P2 and F3 Subunit PETER B
Identification of Applicable 6-Digit HS Subheadings for Products Covered by the Proposed Uruguay Round Pharmaceutical Agreement
Effects of Neuroactive Steroids on the Recombinant GABAA Receptor in Xenopus Oocyte